Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?
Leuk Res
.
2013 Feb;37(2):204-5.
doi: 10.1016/j.leukres.2012.10.023.
Epub 2012 Nov 20.
Authors
Massimo Breccia
1
,
Maria Teresa Voso
,
Giuliana Alimena
Affiliation
1
Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy. breccia@bce.uniroma1.it
PMID:
23174191
DOI:
10.1016/j.leukres.2012.10.023
No abstract available
Publication types
Letter
MeSH terms
Antimetabolites, Antineoplastic / therapeutic use*
Azacitidine / therapeutic use*
Humans
Leukemia, Myelomonocytic, Chronic / drug therapy*
Substances
Antimetabolites, Antineoplastic
Azacitidine